Luminex Corporation (NASDAQ:LMNX), a developer of biological testing technologies, has forged a definitive agreement to buy Madison, Wisconsin-based privately-held diagnostic testing company EraGen Biosciences, Inc. for $34 million in cash. The transaction, which is subject to the clearance of EraGen shareholders and other customary conditions, is expected to complete within the next few weeks.  EraGen, [...]